News & Updates

Show Multimedia Only
Esketamine outperforms quetiapine in head-to-head depression trial

Esketamine outperforms quetiapine in head-to-head depression trial

30 Oct 2023 byJairia Dela Cruz

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial

30 Oct 2023
Remnant cholesterol ups GDM risk in pregnant women

Remnant cholesterol ups GDM risk in pregnant women

29 Oct 2023

Increased levels of remnant cholesterol (RC) appear to elevate the risk of gestational diabetes mellitus (GDM), independent of traditional risk factors, suggests a study. Moreover, pregnant women with high prepregnancy body mass index (BMI), high triglyceride (TG), and high RC levels are at greater GDM risk.

Remnant cholesterol ups GDM risk in pregnant women

29 Oct 2023
Antiviral therapy safe, effective in children with immune-tolerant HBV infection

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

28 Oct 2023

Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.

Antiviral therapy safe, effective in children with immune-tolerant HBV infection

28 Oct 2023